Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > All

Total search results: 10453 | Ordered by Date (descending)
1 2 3 ... 103 104 105  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Glycotope GmbH. (4/29/16). "Press Release: Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer". Berlin. 2016-04-29
4SC AG. (4/29/16). "Press Release: 4SC Sells Operations of Its Discovery Division [Ad hoc announcement according to $ 15 WpHG]". Planegg-Martinsried. 2016-04-29
Eppendorf AG. (4/28/16). "Press Release: Eppendorf Continues Successful Development. Group Sales of €629.1 million (18.5% Growth in Sales) – Income from Operations of €119.3 million (19.0% EBIT Margin)". Hamburg. 2016-04-28
Oncgnostics GmbH. (4/28/16). "Press Release: Oncgnostics GmbH cooperates with Sayre Therapeutics in India". Bangalore & Jena. 2016-04-28
BioQ Pharma Inc.. (4/28/16). "Press Release: BioQ Pharma Expands U.S. License and Supply Agreement to Commercialize Third Ready-to-Use Infusion Product". San Francisco, CA. 2016-04-28
UBS AG. (4/27/16). "Press Release: UBS Raises Record $471m for Oncology Impact Fund". Zurich & Basel. 2016-04-27
VTU Technology GmbH. (4/27/16). "Press Release: VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration". Grambach & Vienna. 2016-04-27
Evotec AG. (4/26/16). "Press Release: Evotec and Ex Scientia Announce Partnership to Discover Bispecific Small Molecule Immuno-oncology Therapeutics". Hamburg & Dundee. 2016-04-26
Eurofins. (4/25/16). "Press Release: Eurofins Achieves 48% Revenue growth and over 10% Organic Growth in Q1 2016". 2016-04-25
Ionicon Analytik GmbH. (4/22/16). "Press Release: Ionicon Launches Autosampler for High Throughput PTR-MS Measurements". Innsbruck. 2016-04-22
Novartis AG. (4/21/16). "Press Release: Novartis Delivered Solid Q1 Despite Gleevec Loss of Exclusivity, Investing Behind New Launches for Long-term Growth". Basel. 2016-04-21
Ablynx N.V.. (4/21/16). "Press Release: Ablynx to Receive an €8 Million Milestone as Boehringer Ingelheim Starts a Phase I Study with an anti-CX3CR1 Nanobody". Ghent & Ingelheim. 2016-04-21
MorphoSys AG. (4/21/16). "Press Release: MorphoSys Provides Update on Results From Partner's Phase 2b/3 RESILIENT Study of Bimagrumab. Bimagrumab Did Not Meet Its Primary Endpoint in Patients with sIBM". 2016-04-21
Aptuit, LLC. (4/21/16). "Press Release: Aptuit Announces Acquisition of Exquiron Biotech AG". Greenwich, CT. 2016-04-21
Illumina, Inc.. (4/21/16). "Press Release: Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents". San Diego, CA. 2016-04-21
Specialized Medical Services-Oncology B.V. (SMS-Oncology). (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". 2016-04-21
Second Genome, Inc.. (4/20/16). "Press Release: Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund". South San Francisco, CA. 2016-04-20
Formycon AG. (4/20/16). "Press Release: Formycon Ends 2015 Fiscal Year with Successful Results [Not for USA, Canada, Australia, Japan, et al.]". Munich. 2016-04-20
Saphetor S.A.. (4/20/16). "Press Release: Saphetor Signs Collaboration with Lausanne University Hospital (CHUV)". Lausanne. 2016-04-20
Enterome Bioscience S.A.. (4/20/16). "Press Release: Enterome Raises €14.5 Million in Series C Financing Round. Nestlé Health Science Invests alongside Existing Investors". Paris & Boston, MA. 2016-04-20
R-Biopharm AG. (4/19/16). "Press Release: R-Biopharm AG to Collaborate with HMNC Brain Health on Complementary Diagnostic Test for Optimization of Depression Treatment". Darmstadt. 2016-04-19
G-Therapeutics B.V.. (4/19/16). "Press Release: G-Therapeutics Raises EUR 36 Million to Develop Novel Neuro-stimulation Therapy for Spinal Cord Injury". Eindhoven & Lausanne. 2016-04-19
Gimv. (4/19/16). "Press Release: Gimv Invests EUR 6 Million in G-Therapeutics as Part of a Total Series A Financing of EUR 26 Million". 2016-04-19
Roche. (4/19/16). "Press Release: Roche Reports Solid Sales Growth in the First Quarter of 2016. Group Sales up 4%1 at Constant Exchange Rates, 5% in Swiss Francs". Basel. 2016-04-19
Evotec AG. (4/19/16). "Press Release: Evotec and Pierre Fabre Sign Multi-year Compound Management Agreement". Hamburg. 2016-04-19
ProBioGen AG. (4/19/16). "Press Release: ProBioGen and Eucodis Sign Agreement to Commercialize C-LiNK, a Novel Antibody Drug Conjugation Technology". Berlin & Vienna. 2016-04-19
MorphoSys AG. (4/18/16). "Press Release: MorphoSys Licensing Partner GSK Starts Phase 2 Study with GSK3196165 (MOR103) in Hand Osteoarthritis". 2016-04-18
Oxford BioTherapeutics Ltd.. (4/18/16). "Press Release: Boehringer Ingelheim Exercises Option on Second Oncology Target Using Oxford BioTherapeutics’ OGAP System". Oxford. 2016-04-18
Euronext. (4/15/16). "Press Release: Euronext Welcomes Swiss Biotechnology Pioneer GeNeuro to Paris Market. Raises €33 Million, Market Capitalisation Totals €190 Million". Paris. 2016-04-15
WuXi AppTec. (4/15/16). "Press Release: WuXi AppTec Acquires Crelux". Munich. 2016-04-15
BioKryo GmbH. (4/15/16). "Press Release: BioKryo GmbH Obtains the American Association of Blood Banks (AABB) Accreditation". 2016-04-15
Agena Bioscience, Inc.. (4/14/16). "Press Release: Agena Bioscience and Horizon Discovery to Launch iPLEX Reference Standards for the MassARRAY System". San Diego, CA & Cambridge. 2016-04-14
GeNeuro S.A.. (4/14/16). "Press Release: GeNeuro Sets Offer Price at €13 per Share [Not for Australia, Canada or Japan]". Geneva. 2016-04-14
Qiagen N.V.. (4/14/16). "Press Release: Qiagen Launches Streamlined Bioinformatics for RNA Sequencing of Liquid Biopsies. RNA-seq Explorer Solution Generates Clear Insights for Cancer »Omics« Analyses". Hilden & Germantown, MD. 2016-04-14
Epigenomics AG. (4/13/16). "Press Release: Epigenomics Receives FDA Approval for Epi proColon". Berlin & Germantown, MD. 2016-04-13
Qiagen N.V.. (4/13/16). "Press Release: Qiagen Partners to Develop Novel Companion Diagnostic in Lung Cancer. Collaboration with Mirati Therapeutics Targets MET Gene Mutations to Personalize Treatment". Hilden & Germantown, MD. 2016-04-13
Evolva Holding S.A.. (4/13/16). "Press Release: Evolva Proposes Gerard Hoetmer as New Board Member". 2016-04-13
Curetis N.V.. (4/12/16). "Press Release: Curetis Publishes Full-year 2015 Financial Results and Introduces 2016 Guidance". Amsterdam & Holzgerlingen. 2016-04-12
Forbion Capital Partners. (4/12/16). "Press Release: Forbion Closes Third Life Sciences Fund, FCF III, Raising over USD200M". Naarden & Munich. 2016-04-12
KWS Saat SE. (4/12/16). "Press Release: KWS to Fully Focus on Hybrid Potato Breeding and Divest its Conventional Seed Potato Business". 2016-04-12
STAT-Diagnostica & Innovation S.L.. (4/11/16). "Press Release: STAT-Diagnostica Announces 25 Million Euros in Series C Financing Led by Gilde Healthcare. Funding Will Be Used to Accelerate Go-to-Market Strategy". Barcelona. 2016-04-11
Genedata AG. (4/11/16). "Press Release: Genedata Announces the Release of Genedata Bioprocess – New Workflow Platform for Biopharmaceutical Development". Basel. 2016-04-11
Bruker Corporation. (4/11/16). "Press Release: Bruker Introduces Important MALDI Biotyper Enhancements at ECCMID 2016 – New Disposable MBT Biotargets 96, MBT Subtyping and Carbapenem Resistance Tests". Amsterdam. 2016-04-11
Evolva Holding S.A.. (4/11/16). "Press Release: Evolva to Co-develop Next-generation Materials with US Navy". 2016-04-11
Boehringer Ingelheim. (4/7/16). "Press Release: Giotrif (afatinib) Approved in Europe as New Oral Treatment Option for Patients with Squamous Cell Carcinoma of the Lung". Ingelheim. 2016-04-07
Kiadis Pharma B.V.. (4/7/16). "Press Release: Kiadis Pharma Proposes Robert Soiffer and Berndt Modig as Its New Supervisory Board Members". Amsterdam. 2016-04-07
MorphoSys AG. (4/7/16). "Press Release: MorphoSys and Galapagos Initiate Phase 1 Study in Joint Antibody Program MOR106". 2016-04-07
Analytik Jena AG. (4/7/16). "Press Release: Analytik Jena Launches a New Model for the PlasmaQuant® PQ 9000 Series of ICP-OES Instruments". Jena. 2016-04-07
BioSilta Ltd.. (4/6/16). "Press Release: BioSilta Ltd Acquires Worldwide Rights to CyDisCo Technology from University of Oulu to Produce Proteins with Multi-industry Applications". Cambridge. 2016-04-06
Lumos Pharma. (4/6/16). "Press Release: Lumos Pharma Raises $34 Million in Series B Financing". Austin, TX. 2016-04-06
Thermosome GmbH. (4/6/16). "Press Release: Thermosome Receives €2.7m Research Grant from the German Federal Ministry of Education and Research (BMBF)". Martinsried. 2016-04-06
Thermosome GmbH. (4/6/16). "Press Release: Thermosome Raises €4.6m with First financing Round and a Research Grant from the German Government". Martinsried. 2016-04-06
Pressure BioSciences, Inc.. (4/6/16). "Press Release: Company Reports Increases in Total/Products/Grant Revenue & Product Gross Margins". South Easton, MA. 2016-04-06
Meiogenix S.A.S.. (4/6/16). "Press Release: Meiogenix Announces a Licensing Agreement with Bayer to Apply SpiX Technology in Crops". Paris. 2016-04-06
Merck KGaA. (4/6/16). "Press Release: Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy Test for Colorectal Cancer Patients". Darmstadt. 2016-04-06
Bruker Corporation. (4/6/16). "Press Release: The Weizmann Institute of Science Selects Bruker GigaHertz NMR Technology to Enable Advanced Structural Biology Research". Rehovot & Billerica, MA. 2016-04-06
Markes International Ltd.. (4/5/16). "Press Release: New Paper in Analytical Chemistry – Select-eV Unravels the Composition of Complex Motor Oils". 2016-04-05
Evolva Holding S.A.. (4/5/16). "Press Release: Evolva Gains Exclusive License to Develop and Commercialise Nootkatone Globally for Pest Control". 2016-04-05
Qiagen N.V.. (4/5/16). "Press Release: Qiagen Partners with IT Leaders on Novel Infrastructure for Genomics". Boston, MA & Hilden. 2016-04-05
Metabomed Ltd.. (4/4/16). "Press Release: Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing". Yavne. 2016-04-04
Anergis S.A.. (4/4/16). "Press Release: Anergis Closes CHF 5 Million Financing Round Extension to Conduct Large-Scale ATIBAR Trial with Ultra-Fast Allergy Immunotherapy AllerT". Epalinges. 2016-04-04
Boehringer Ingelheim. (4/4/16). "Press Release: Interim Phase III Data Show Praxbind (Idarucizumab) Reverses Dabigatran (Pradaxa) in Emergency Situations". Ingelheim. 2016-04-04
Agena Bioscience, Inc.. (4/4/16). "Press Release: Agena Bioscience Launches In Vitro Diagnostic Tests for Lung and Colon Cancer in Europe. Company Achieves CE-IVD mark and Enters Routine Molecular Diagnostics Market". San Diego, CA & Hamburg. 2016-04-04
MorphoSys AG. (4/4/16). "Press Release: Ad hoc – MorphoSys Sues Janssen Biotech and Genmab for Patent Infringement". 2016-04-04
Medigene AG. (4/4/16). "Press Release: Medigene Sells Partial Stake in Immunocore". Martinsried. 2016-04-04
Stratec Biomedical AG. (4/1/16). "Press Release: Stratec Completes Acquisition of Diatron". Birkenfeld. 2016-04-01
Medigene AG. (4/1/16). "Press Release: Medigene Announces Start of Phase II Trial with DC Vaccines and Upcoming Milestone Payment". Martinsried. 2016-04-01
Endress+Hauser AG. (4/1/16). "Press Release: Endress+Hauser Completes Takeover of Analytik Jena. Remaining Minority Shareholders Receive Cash Compensation". 2016-04-01
Bristol-Myers Squibb Company. (4/1/16). "Press Release: Bristol-Myers Squibb Completes Previously Announced Acquisition of Padlock Therapeutics, Inc.". New York, NY. 2016-04-01
Biogen, Inc.. (4/1/16). "Press Release: Flixabi, an Infliximab Biosimilar Candidate Referencing Remicade, Receives Positive CHMP Opinion". Zug. 2016-04-01
Novartis AG. (3/31/16). "Press Release: Novartis Publishes Updated 2015 Segment Financials Reflecting New Division Structure". Basel. 2016-03-31
Roche. (3/31/16). "Press Release: Roche to Initiate Testing for Zika Virus at U.S. Blood Centres under FDA Investigational New Drug Application Protocol". Basel. 2016-03-31
Fusion Antibodies Ltd.. (3/31/16). "Press Release: Fusion Antibodies and MAB Discovery Announce Project Collaboration". 2016-03-31
Thermo Fisher Scientific Inc.. (3/31/16). "Press Release: Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders". Waltham, MA & Santa Clara, CA. 2016-03-31
Amal Therapeutics S.A.. (3/30/16). "Press Release: Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund". Geneva & Ingelheim. 2016-03-30
Genohm. (3/30/16). "Press Release: Genohm Opens Its New US Branch in Durham, NC". Lausanne & Durham, NC. 2016-03-30
Affimed N.V.. (3/30/16). "Press Release: Affimed Reports Financial Results for Fourth Quarter and Year End 2015. Successful Financings Closed and US Presence Established". Heidelberg. 2016-03-30
CureVac AG. (3/30/16). "Press Release: CureVac Appoints Leading Experts to Its Scientific Advisory Board". Tübingen. 2016-03-30
Epigenomics AG. (3/30/16). "Press Release: Epigenomics Enters Strategic License and Development Agreement with BioChain on Novel, Blood-based Lung Cancer Test". Berlin & Germantown, MD. 2016-03-30
Evolva Holding S.A.. (3/30/16). "Press Release: Evolva Publishes Financial Results for 2015 and Updates on Projects". 2016-03-30
Boehringer Ingelheim. (3/30/16). "Press Release: Boehringer Ingelheim Venture Fund Invests in Amal Therapeutics to Develop Novel Therapeutic Colorectal Cancer Vaccine". Ingelheim & Geneva. 2016-03-30
4SC AG. (3/30/16). "Press Release: 4SC Announces Results for Financial Year 2015". Planegg-Martinsried. 2016-03-30
Gadeta B.V.. (3/29/16). "Press Release: Gadeta Closes EUR 7 Million Series A Financing to Advance Novel Cancer Immunotherapies to the Clinic". Utrecht. 2016-03-29
Qiagen N.V.. (3/29/16). "Press Release: Qiagen to Submit Conditional Voluntary Takeover Offer for Shares of Exiqon A/S [Not for US, CA, JP, AU, ZA, et al.] Transaction will expand leadership position in RNA technologies". Venlo. 2016-03-29
Newron Pharmaceuticals S.p.A.. (3/29/16). "Press Release: Newron Receives Complete Response Letter from US FDA for Xadago (safinamide)". Milan. 2016-03-29
Ligand Pharmaceuticals Inc.. (3/28/16). "Press Release: Ligand Enters into OmniAb Platform License Agreement with ABBA Therapeutics". San Diego, CA. 2016-03-28
4SC AG. (3/24/16). "Press Release: Chairman of the Management Board Enno Spillner Will Not Extend His Current Term of Office, But Will Leave the Company After a Transitional Period Ending 30 June 2016". Planegg-Martinsried. 2016-03-24
ITM Isotopen Technologien München AG. (3/24/16). "Press Release: ITM and Scil Proteins Announce New Partnership for Targeted Radio Conjugates". Garching & Halle/Saale. 2016-03-24
Bristol-Myers Squibb Company. (3/23/16). "Press Release: Bristol-Myers Squibb to Acquire Padlock Therapeutics, Inc.". New York, NY & Cambridge, MA. 2016-03-23
Probiodrug AG. (3/23/16). "Press Release: Probiodrug Appoints Mark Booth as Chief Business Officer". Halle (Saale). 2016-03-23
Stratec Biomedical AG. (3/23/16). "Press Release: Stratec to Acquire Hematology System Specialist Diatron". Birkenfeld. 2016-03-23
bm-t Beteiligungsmanagement Thüringen GmbH. (3/23/16). "Press Release: High-Tech Gründerfonds (HTGF) and bm|t Renew Their Cooperation Agreement". 2016-03-23
Cosmo Pharmaceuticals S.A.. (3/23/16). "Press Release: Record Profits for Cosmo in 2015". Luxembourg. 2016-03-23
Topas Therapeutics GmbH. (3/22/16). "Press Release: Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders". Hamburg. 2016-03-22
Gimv. (3/22/16). "Press Release: Gimv Invests EUR 4 Million in Biopharma Company Topas Therapeutics Confirming Its Commitment to Life Sciences". Antwerp & Munich. 2016-03-22
bioMérieux S.A.. (3/22/16). "Press Release: bioMérieux and Copan Announce the First Commercial Success of their Collaboration for the Automation and Efficiency of Microbiology laboratories". Marcy l’Étoile. 2016-03-22
Wilex AG. (3/22/16). "Press Release: Wilex Announces Financial Figures for the 2015 Financial Year and Reports on Course of Business". Munich. 2016-03-22
Pieris Pharmaceuticals, Inc.. (3/22/16). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2015 Financial Results and Corporate Update". Boston, MA. 2016-03-22
Metrion Biosciences Ltd.. (3/21/16). "Press Release: Metrion Biosciences and EU Partners Receive €2.2M Funding Award under Eurostars SME Programme". Cambridge. 2016-03-21
OSE Pharma S.A.. (3/21/16). "Press Release: 2015 Annual Results in Line with Forecasts, and Significant Clinical Advances. 2016 Outlook – Further Development and Merger Project with Effimune". Paris. 2016-03-21
1 2 3 ... 103 104 105  next pagenext page



Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] Roadshow Season Spring 2016 JPMorgan Healthcare 2017 600x560px

» top

Advertisements

Picture [iito] Roadshow Spring 2016 Offer 120x180px Picture EBD Group ChinaBio Partnering Forum 2016 CBPF Suzhou May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px